Dr. Laufman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2975 Donnylane Blvd
Columbus, OH 43235Phone+1 614-366-8380Fax+1 614-366-8557
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1975 - 1976
- Ohio State University HospitalResidency, Internal Medicine, 1974 - 1975
- UPMC Medical EducationResidency, Internal Medicine, 1972 - 1974
- University of Pittsburgh School of MedicineClass of 1972
Certifications & Licensure
- OH State Medical License 1976 - 2016
Clinical Trials
- A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer Start of enrollment: 2003 Oct 01
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Publications & Presentations
PubMed
- 142 citationsAdenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II StudyMartin Schuler, R. Herrmann, J. L.P. De Greve, A. K. Stewart, U. Gatzemeier
Journal of Clinical Oncology. 2001-03-15 - 357 citationsRandomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer With...Joaquim Bellmunt, Hans von der Maase, Graham M. Mead, Iwona Skoneczna, Maria De Santis
Journal of Clinical Oncology. 2012-04-01 - 152 citationsRandomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.Stephen E. Jones, Eric P. Winer, Charles L. Vogel, Leslie R. Laufman, Laura F. Hutchins
Journal of Clinical Oncology. 1995-10-01
Grant Support
- Cancer Information ExchanceNational Cancer Institute1998
- Cancer Information Exchange (CIX)National Cancer Institute1997
- Columbus Community Clinical Oncology ProgramNational Cancer Institute1995–1996
- Columbus Community Clincal Oncology ProgramNational Cancer Institute1991–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: